A paradigm shift is also required in treatment goals and in performance indicators: reply
نویسندگان
چکیده
منابع مشابه
a study on rate making and required reserves determination in reinsurance market: a simulation
reinsurance is widely recognized as an important instrument in the capital management of an insurance company as well as its risk management tool. this thesis is intended to determine premium rates for different types of reinsurance policies. also, given the fact that the reinsurance coverage of every company depends upon its reserves, so different types of reserves and the method of their calc...
Fat Grafting Technique, A Paradigm Shift in the Treatment of Tuberous Breast
BACKGROUND The tuberous breast syndrome is a condition that affects young women and can bring on serious disorders of self-esteem. There are numerous surgical techniques to correct this condition, but most of them include the use of breast implants to replace lack of volume. Nowadays, patients are increasingly becoming more demanding to get a definitive solution with minimal aesthetic sequelae...
متن کاملScreening for rheumatic heart disease: is a paradigm shift required?
This focused review presents a critical appraisal of the World Heart Federation criteria for the echocardiographic diagnosis of rheumatic heart disease (RHD) and its performance in African RHD screening programmes. It identifies various logistical and methodological problems that negatively influence the current guideline's performance. The authors explore novel RHD screening methodology that c...
متن کاملAn Information Paradigm Shift is Required to Realize EHR Benefits
The use of EHRs and the benefits from them are significant for healthcare and health informatics. Data form the basis for any EHR and its potential to realize these benefits. This paper considers the housing of information and knowledge management in an EHR system. Are we experiencing a revolution in healthcare? Findings from an investigation of alternative approaches, followed by an evaluation...
متن کاملParadigm-HF: a Paradigm Shift in Heart Failure Treatment?
DOI: 10.5935/abc.20160009 In the first semester of this year, the U.S. Food and Drug Administration (FDA) approved a new drug for the treatment of heart failure, LCZ696, commercially known as Entresto. This new treatment option was evaluated by the FDA on a priority basis (fast track designation), which allowed a faster release than usual. In Brazil, the drug is being evaluated by the National ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Internal Medicine
سال: 2010
ISSN: 0954-6820,1365-2796
DOI: 10.1111/j.1365-2796.2009.02177.x